Sage Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 11, 2025
2025年1月29日 - 6:30AM
ビジネスワイヤ(英語)
Sage Therapeutics, Inc. (NASDAQ: SAGE), today announced that it
will host a live webcast on Tuesday, February 11, 2025 at 4:30 p.m.
ET to review fourth quarter and full year 2024 financial results
and discuss recent business updates.
The webcast can be accessed on the Investor page of Sage’s
website at investor.sagerx.com. A replay of the webcast will be
available following the completion of the event and will be
archived for up to 30 days.
About Sage Therapeutics
Sage Therapeutics (Nasdaq: SAGE) is a biopharmaceutical company
committed to our mission of pioneering solutions to deliver
life-changing brain health medicines, so every person can thrive.
Sage developed the only two FDA-approved treatments indicated for
postpartum depression and is advancing a pipeline to target unmet
needs in brain health. Sage was founded in 2010 and is
headquartered in Cambridge, Mass. Find out more at www.sagerx.com
or engage with us on Facebook, LinkedIn, Instagram, and X.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250128429244/en/
Investor Contact Ashley Kaplowitz
Ashley.Kaplowitz@sagerx.com Media Contact Francesca Dellelci
Francesca.Dellelci@sagerx.com
Sage Therapeutics (NASDAQ:SAGE)
過去 株価チャート
から 1 2025 まで 2 2025
Sage Therapeutics (NASDAQ:SAGE)
過去 株価チャート
から 2 2024 まで 2 2025